Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers

Chemosaturation (CS; CHEMOSAT®, Delcath Systems Inc.) temporarily administers melphalan into the liver by percutaneous hepatic perfusion (PHP). CS-PHP can effectively control growth in liver tumors, but efficacy and tolerability of sequential treatments are unclear. We analyzed outcomes of sequentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Veelken, Rhea, Maiwald, Bettina, Strocka, Steffen, Petersen, Tim-Ole, Moche, Michael, Ebel, Sebastian, Denecke, Timm, Rehak, Matus, Struck, Manuel Florian, Forstmeyer, Dirk, Rademacher, Sebastian, Seehofer, Daniel, Berg, Thomas, van Bömmel, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555734/
https://www.ncbi.nlm.nih.gov/pubmed/34716470
http://dx.doi.org/10.1007/s00270-021-02983-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555734/
https://www.ncbi.nlm.nih.gov/pubmed/34716470
http://dx.doi.org/10.1007/s00270-021-02983-2

Ejemplares similares